ARTICLE | Clinical News
Microlin Bio preclinical data
October 12, 2015 7:00 AM UTC
In a mouse xenograft model of lung cancer, thrice-weekly 1 mg/kg IV AM-21 for 1 week followed by once-weekly AM-21 led to significant tumor regression or no tumor growth compared to untreated controls...